A landmark xenotransplantation achievement has been reported with the first genetically modified pig lung transplant functioning in a brain-dead human recipient for nine days. The procedure demonstrated no hyperacute rejection, although ischemia reperfusion injury and antibody-mediated rejection occurred post-transplant. This progress extends the horizons of organ transplant solutions amidst ongoing research into overcoming immune challenges.